Rival Can't Avoid Drugmaker's False Ad Claim Over Pain Med

By Emily Field · August 26, 2024, 8:24 PM EDT

A Texas federal magistrate on Monday advised against dismissing Pacira Biosciences Inc.'s suit against a rival, finding that Pacira had alleged enough facts to show QuVa Pharma Inc.'s advertising is deceptive...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Pacira BioSciences, Inc. v. QuVa Pharma, Inc.

Case Number

4:23-cv-04147

Court

Texas Southern

Nature of Suit

Other Statutory Actions

Date Filed

November 01, 2023